Bio-Connect

InVivoMAb anti-human CD44

BE0262
Bio X Cell
ApplicationsImmunoFluorescence, Western Blot, Neutralisation/Blocking
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoMAb anti-human CD44
  • Delivery Days Customer
    7
  • Applications
    ImmunoFluorescence, Western Blot, Neutralisation/Blocking
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    Hermes-1
  • Concentration
    4-11 mg/ml
  • Estimated Purity
    >95%
  • Host
    Rat
  • Isotype
    IgG2a
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Zhao C, Thompson BJ, Chen K, et al. The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44. Oncotarget. 2019,10(61):6561-6576. doi: 10.18632/oncotarget.27302
    Read this paper
  • Lin CY, Kolliopoulos C, Huang CH, et al. High levels of serum hyaluronan is an early predictor of dengue warning signs and perturbs vascular integrity. EBioMedicine. 2019,48:425-441. doi: 10.1016/j.ebiom.2019.09.014
    Read this paper
  • Simonson AW, Lawanprasert A, Goralski TDP, et al. Bioresponsive peptide-polysaccharide nanogels - A versatile delivery system to augment the utility of bioactive cargo. Nanomedicine. 2019,17:391-400. doi: 10.1016/j.nano.2018.10.008
    Read this paper
  • Jokela T, Oikari S, Takabe P, et al. Interleukin-1β-induced Reduction of CD44 Ser-325 Phosphorylation in Human Epidermal Keratinocytes Promotes CD44 Homomeric Complexes, Binding to Ezrin, and Extended, Monocyte-adhesive Hyaluronan Coats. J Biol Chem. 2015,290(19):12379-93. doi: 10.1074/jbc.M114.620864
    Read this paper
  • Kim Y, Kumar S. CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility. Mol Cancer Res. 2014,12(10):1416-29. doi: 10.1158/1541-7786.MCR-13-0629
    Read this paper
  • Olofsson B, Porsch H, Heldin P. Knock-down of CD44 regulates endothelial cell differentiation via NFκB-mediated chemokine production. PLoS One. 2014,9(3):e90921. doi: 10.1371/journal.pone.0090921
    Read this paper
  • Qu C, Rilla K, Tammi R, et al. Extensive CD44-dependent hyaluronan coats on human bone marrow-derived mesenchymal stem cells produced by hyaluronan synthases HAS1, HAS2 and HAS3. Int J Biochem Cell Biol. 2014,48:45-54. doi: 10.1016/j.biocel.2013.12.016
    Read this paper
  • Purushothaman A, Toole BP. Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization. J Biol Chem. 2014,289(9):5499-509. doi: 10.1074/jbc.M113.532143
    Read this paper
  • Picker LJ, De los Toyos J, Telen MJ, et al. Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. J Immunol. 1989,142(6):2046-51.
    Read this paper